Cholesterol in brain disease: sometimesdeterminant and frequently implicated
- Autores
- Martín, Mauricio Gerardo; Pfrieger, Frank; Dotti, Carlos G.
- Año de publicación
- 2014
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Cholesterol is essential for neuronal physiology, both during development and in the adult life: as a major component of cell membranes and precursor of steroid hormones, it contributes to the regulation of ion permeability, cell shape, cell–cell interaction, and transmembrane signaling. Consistently, hereditary diseases with mutations in cholesterol‐related genes result in impaired brain function during early life. In addition, defects in brain cholesterol metabolism may contribute to neurological syndromes, such as Alzheimer's disease (AD), Huntington's disease (HD), and Parkinson's disease (PD), and even to the cognitive deficits typical of the old age. In these cases, brain cholesterol defects may be secondary to disease‐causing elements and contribute to the functional deficits by altering synaptic functions. In the first part of this review, we will describe hereditary and non‐hereditary causes of cholesterol dyshomeostasis and the relationship to brain diseases. In the second part, we will focus on the mechanisms by which perturbation of cholesterol metabolism can affect synaptic function.
Fil: Martín, Mauricio Gerardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigación Médica Mercedes y Martín Ferreyra. Universidad Nacional de Córdoba. Instituto de Investigación Médica Mercedes y Martín Ferreyra; Argentina
Fil: Pfrieger, Frank. Université de Strasbourg; Francia
Fil: Dotti, Carlos G.. Universidad Autónoma de Madrid; España - Materia
-
Brain Disease
Cholesterol Metabolism
Cognition - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/31626
Ver los metadatos del registro completo
id |
CONICETDig_7e9cc52a383085591d6d3180ffe4d3a0 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/31626 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Cholesterol in brain disease: sometimesdeterminant and frequently implicatedMartín, Mauricio GerardoPfrieger, FrankDotti, Carlos G.Brain DiseaseCholesterol MetabolismCognitionhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Cholesterol is essential for neuronal physiology, both during development and in the adult life: as a major component of cell membranes and precursor of steroid hormones, it contributes to the regulation of ion permeability, cell shape, cell–cell interaction, and transmembrane signaling. Consistently, hereditary diseases with mutations in cholesterol‐related genes result in impaired brain function during early life. In addition, defects in brain cholesterol metabolism may contribute to neurological syndromes, such as Alzheimer's disease (AD), Huntington's disease (HD), and Parkinson's disease (PD), and even to the cognitive deficits typical of the old age. In these cases, brain cholesterol defects may be secondary to disease‐causing elements and contribute to the functional deficits by altering synaptic functions. In the first part of this review, we will describe hereditary and non‐hereditary causes of cholesterol dyshomeostasis and the relationship to brain diseases. In the second part, we will focus on the mechanisms by which perturbation of cholesterol metabolism can affect synaptic function.Fil: Martín, Mauricio Gerardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigación Médica Mercedes y Martín Ferreyra. Universidad Nacional de Córdoba. Instituto de Investigación Médica Mercedes y Martín Ferreyra; ArgentinaFil: Pfrieger, Frank. Université de Strasbourg; FranciaFil: Dotti, Carlos G.. Universidad Autónoma de Madrid; EspañaNature Publishing Group2014-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/31626Martín, Mauricio Gerardo; Pfrieger, Frank; Dotti, Carlos G.; Cholesterol in brain disease: sometimesdeterminant and frequently implicated; Nature Publishing Group; Embo Reports; 15; 10; 9-2014; 1036-10521469-221XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.15252/embr.201439225info:eu-repo/semantics/altIdentifier/url/http://embor.embopress.org/content/15/10/1036info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:42:24Zoai:ri.conicet.gov.ar:11336/31626instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:42:24.904CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Cholesterol in brain disease: sometimesdeterminant and frequently implicated |
title |
Cholesterol in brain disease: sometimesdeterminant and frequently implicated |
spellingShingle |
Cholesterol in brain disease: sometimesdeterminant and frequently implicated Martín, Mauricio Gerardo Brain Disease Cholesterol Metabolism Cognition |
title_short |
Cholesterol in brain disease: sometimesdeterminant and frequently implicated |
title_full |
Cholesterol in brain disease: sometimesdeterminant and frequently implicated |
title_fullStr |
Cholesterol in brain disease: sometimesdeterminant and frequently implicated |
title_full_unstemmed |
Cholesterol in brain disease: sometimesdeterminant and frequently implicated |
title_sort |
Cholesterol in brain disease: sometimesdeterminant and frequently implicated |
dc.creator.none.fl_str_mv |
Martín, Mauricio Gerardo Pfrieger, Frank Dotti, Carlos G. |
author |
Martín, Mauricio Gerardo |
author_facet |
Martín, Mauricio Gerardo Pfrieger, Frank Dotti, Carlos G. |
author_role |
author |
author2 |
Pfrieger, Frank Dotti, Carlos G. |
author2_role |
author author |
dc.subject.none.fl_str_mv |
Brain Disease Cholesterol Metabolism Cognition |
topic |
Brain Disease Cholesterol Metabolism Cognition |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Cholesterol is essential for neuronal physiology, both during development and in the adult life: as a major component of cell membranes and precursor of steroid hormones, it contributes to the regulation of ion permeability, cell shape, cell–cell interaction, and transmembrane signaling. Consistently, hereditary diseases with mutations in cholesterol‐related genes result in impaired brain function during early life. In addition, defects in brain cholesterol metabolism may contribute to neurological syndromes, such as Alzheimer's disease (AD), Huntington's disease (HD), and Parkinson's disease (PD), and even to the cognitive deficits typical of the old age. In these cases, brain cholesterol defects may be secondary to disease‐causing elements and contribute to the functional deficits by altering synaptic functions. In the first part of this review, we will describe hereditary and non‐hereditary causes of cholesterol dyshomeostasis and the relationship to brain diseases. In the second part, we will focus on the mechanisms by which perturbation of cholesterol metabolism can affect synaptic function. Fil: Martín, Mauricio Gerardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigación Médica Mercedes y Martín Ferreyra. Universidad Nacional de Córdoba. Instituto de Investigación Médica Mercedes y Martín Ferreyra; Argentina Fil: Pfrieger, Frank. Université de Strasbourg; Francia Fil: Dotti, Carlos G.. Universidad Autónoma de Madrid; España |
description |
Cholesterol is essential for neuronal physiology, both during development and in the adult life: as a major component of cell membranes and precursor of steroid hormones, it contributes to the regulation of ion permeability, cell shape, cell–cell interaction, and transmembrane signaling. Consistently, hereditary diseases with mutations in cholesterol‐related genes result in impaired brain function during early life. In addition, defects in brain cholesterol metabolism may contribute to neurological syndromes, such as Alzheimer's disease (AD), Huntington's disease (HD), and Parkinson's disease (PD), and even to the cognitive deficits typical of the old age. In these cases, brain cholesterol defects may be secondary to disease‐causing elements and contribute to the functional deficits by altering synaptic functions. In the first part of this review, we will describe hereditary and non‐hereditary causes of cholesterol dyshomeostasis and the relationship to brain diseases. In the second part, we will focus on the mechanisms by which perturbation of cholesterol metabolism can affect synaptic function. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-09 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/31626 Martín, Mauricio Gerardo; Pfrieger, Frank; Dotti, Carlos G.; Cholesterol in brain disease: sometimesdeterminant and frequently implicated; Nature Publishing Group; Embo Reports; 15; 10; 9-2014; 1036-1052 1469-221X CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/31626 |
identifier_str_mv |
Martín, Mauricio Gerardo; Pfrieger, Frank; Dotti, Carlos G.; Cholesterol in brain disease: sometimesdeterminant and frequently implicated; Nature Publishing Group; Embo Reports; 15; 10; 9-2014; 1036-1052 1469-221X CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.15252/embr.201439225 info:eu-repo/semantics/altIdentifier/url/http://embor.embopress.org/content/15/10/1036 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Nature Publishing Group |
publisher.none.fl_str_mv |
Nature Publishing Group |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613336670404608 |
score |
13.070432 |